Method for treating mild cognitive impairment and for preventing or delaying Alzheimer's disease

Details for Australian Patent Application No. 2004218871 (hide)

Owner Merck Sharp & Dohme Limited Merck & Co. Inc.

Inventors Shearman, Mark Steven; Turner, Mervyn

Agent Spruson & Ferguson

Pub. Number AU-A-2004218871

PCT Pub. Number WO2004/080459

Priority 60/454,589 14.03.03 US

Filing date 8 March 2004

Wipo publication date 23 September 2004

International Classifications

A61P 025/28 Drugs for disorders of the nervous system

A61K 031/445 - Non-condensed piperidines, e.g. piperocaine

Event Publications

29 September 2005 PCT application entered the National Phase

  PCT publication WO2004/080459 Priority application(s): WO2004/080459

29 November 2007 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004218872-A fluid dispensing device with stopper

2004218870-Improvements relating to skin prickers